We've found
5,401
archived clinical trials in
Alzheimer Disease
We've found
5,401
archived clinical trials in
Alzheimer Disease
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Updated: 1/1/1970
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Status: Archived
Updated: 1/1/1970
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Updated: 1/1/1970
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Updated: 1/1/1970
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Updated: 1/1/1970
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Updated: 1/1/1970
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Updated: 1/1/1970
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Updated: 1/1/1970
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Updated: 1/1/1970
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Updated: 1/1/1970
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Updated: 1/1/1970
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Updated: 1/1/1970
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Updated: 1/1/1970
A 90-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study in Patients With Mild Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Abeta-specific Antibody Response Following Repeated i.m. Injections of Adjuvanted CAD106
Status: Archived
Updated: 1/1/1970
A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's
Plasma Amyloid Beta Species After a Single Solanezumab Infusion in Nondemented Individuals and Those With Mild Dementia of the Alzheimer's Type
Status: Archived
A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's
Updated: 1/1/1970
Plasma Amyloid Beta Species After a Single Solanezumab Infusion in Nondemented Individuals and Those With Mild Dementia of the Alzheimer's Type
Status: Archived
Updated: 1/1/1970
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
An Exploratory, Open-label, Non-randomized Phase 0 Study to Evaluate Efficacy & Safety of MNI-558 Positron Emission Tomography for Detection/Exclusion of Cerebral Amyloid Beta in Patients w/ Alzheimer Disease Compared to Healthy Volunteers
Status: Archived
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
Updated: 1/1/1970
An Exploratory, Open-label, Non-randomized Phase 0 Study to Evaluate Efficacy & Safety of MNI-558 Positron Emission Tomography for Detection/Exclusion of Cerebral Amyloid Beta in Patients w/ Alzheimer Disease Compared to Healthy Volunteers
Status: Archived
Updated: 1/1/1970
Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center, Biomarker, Safety, and Pharmacokinetic Study of Bapineuzumab (AAB-001) Administered Subcutaneously at Monthly Intervals in Subjects With Mild to Moderate Alzheimer's Disease
Status: Archived
Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease
Updated: 1/1/1970
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center, Biomarker, Safety, and Pharmacokinetic Study of Bapineuzumab (AAB-001) Administered Subcutaneously at Monthly Intervals in Subjects With Mild to Moderate Alzheimer's Disease
Status: Archived
Updated: 1/1/1970
Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center, Biomarker, Safety, and Pharmacokinetic Study of Bapineuzumab (AAB-001) Administered Subcutaneously at Monthly Intervals in Subjects With Mild to Moderate Alzheimer's Disease
Status: Archived
Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease
Updated: 1/1/1970
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center, Biomarker, Safety, and Pharmacokinetic Study of Bapineuzumab (AAB-001) Administered Subcutaneously at Monthly Intervals in Subjects With Mild to Moderate Alzheimer's Disease
Status: Archived
Updated: 1/1/1970